tiprankstipranks
Dyne Therapeutics price target raised to $31 from $20 at Chardan
PremiumThe FlyDyne Therapeutics price target raised to $31 from $20 at Chardan
2M ago
Dyne Therapeutics price target raised to $37 from $33 at Guggenheim
PremiumThe Fly
Dyne Therapeutics price target raised to $37 from $33 at Guggenheim
2M ago
Dyne Therapeutics price target raised to $29 from $27 at Piper Sandler
PremiumThe Fly
Dyne Therapeutics price target raised to $29 from $27 at Piper Sandler
2M ago
Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
PremiumPress ReleasesDyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
2M ago
Dyne Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Dyne Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference
PremiumPress Releases
Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference
2M ago
Dyne Therapeutics jumps as Bloomberg says company seeing takeover interest
PremiumThe FlyDyne Therapeutics jumps as Bloomberg says company seeing takeover interest
3M ago
Dyne Therapeutics seeing takeover interest, weighing options, Bloomberg says
PremiumThe Fly
Dyne Therapeutics seeing takeover interest, weighing options, Bloomberg says
3M ago
Dyne Therapeutics trading halted, volatility trading pause
PremiumThe Fly
Dyne Therapeutics trading halted, volatility trading pause
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100